Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -8.67 | 14.84 |
| PEG Ratio (TTM) | 0.13 | -0.11 |
| P/S Ratio (TTM) | 0.60 | 2.61 |
| P/B Ratio (TTM) | 0.39 | 1.36 |
| P/FCF Ratio (TTM) | -3.90 | 5.85 |
| Price to 5YR AVG Earnings Ratio | 4.43 | 15.03 |
| Price to 5YR AVG FCF Ratio | 1.73 | 9.32 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.27% | 0.94% |
| ROE (TTM) | -4.60% | 9.38% |
| Net Profit Margin (TTM) | -6.98% | 16.48% |
| ROIC 5YR AVG | 4.75% | 17.23% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -93.23% | 61.85% | 1.49% |
| Revenue | 20.75% | -1.72% | -11.03% |
| Net Income | -92.05% | 47.49% | -8.25% |
| Cash Flow | -171.08% | 2,953.67% | 1,758.17% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 12.29 |
| Quick Ratio (TTM) | N/A | 12.50 |
| D/E Ratio (TTM) | 3.94 | 1.03 |
| Interest Coverage (TTM) | -0.11 | 0.73 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.38 | 0.43 |
| LTL to 5YR AVG FCF | 1.83 | 5.75 |
| Shares Outstanding Growth 5YR AVG | -6.91% | 60.49% |